![Stephen Machatha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Machatha
No open positions remaining
Net worth: 388 518 $ as of 31/05/2026
Profile
Stephen G.
Machatha worked at Aldeyra Therapeutics, Inc. from 2016 to 2026, serving as Chief Development Officer from 2021 to 2026.
Dr. Machatha completed undergraduate, graduate, and doctorate degrees at the University of Arizona.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/04/2026 | 222,010 ( 0.37% ) | 388 518 $ | 31/05/2026 |
Former positions of Stephen Machatha
| Companies | Position | End |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Corporate Officer/Principal | 31/03/2026 |
Training of Stephen Machatha
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Stephen Machatha
